Skip to main content
Equibles

KIMS · Krishna Institute of Medical Sciences Limited

Use KIMS with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research KIMS.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
729.65 INR +2.35 (+0.32%) At close · Nov 13
Rebalance outlook locked
Market Cap
306.46B INR
Shares
420.01M
Volume · Nov 13 269.53K Avg daily vol (3M) 495.55K

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Investor day
Close729.65 INR Open725.00 INR Day720.05–736.00 INR 52W close582.10–850.65 INR Avg vol 30d434K Last earningsNov 5, 2026 DataSep 2024–Nov 2026

Raw chart and full-history price indicators begin at the captured split on Sep 13, 2024; bars on opposite sides are not compared.

Latest documents

2026
Nov 5
Earnings call
Q2 revenue rises 41.3% as EBITDA reaches INR 279 crore

Kim's Hospital reported Q2 FY27 revenue of INR 1363 crore, up 41.3% year-on-year, with EBITDA of INR 279 crore and a 20.5% margin. Cash and cash equivalents were INR 420 crores as on 30th September 2026.

3 source passages
Kim's Hospital Q2 FY27 Earning Conference Call Total revenue of INR 1363 crore, a growth of 41.3% on year-on-year and 14% on quarter-on-quarter basis. EBITDA of INR 279 crore, a growth of 34% on year-on-year and 16.3% on quarter-on-quarter basis. EBITDA margin stood at 20.5% versus 20.1% in quarter-on-quarter FI 27. and 21.7% in quarter 2 FY26. Cash and cash equivalents, including cash, bank balance, deposits with a maturity of less than 12 months, and investment in mutual funds of INR 420 crores, as on 30th September 2026. Open the document at this passage
All documents

Quarterly results

Revenue Net income Net loss
▲27.5% 7.72B INR 925.00M INR '25 Q3 ▲25.7% 7.97B INR 1.02B INR '25 Q4 ▲26.6% 8.72B INR 786.00M INR '26 Q1 ▲23.6% 9.61B INR 671.00M INR '26 Q2 ▲29.2% 9.98B INR 534.00M INR '26 Q3 ▲34.8% 10.75B INR 425.00M INR '26 Q4 ▲35.3% 11.79B INR 415.00M INR '27 Q1 LATEST ▲39.9% 13.44B INR 750.00M INR '27 Q2

Technicals

trend & momentum for long-term holders illustrative — not investment advice
Price context
position in its 52-week range
Range low 582.10 INR Now 729.65 INR · 55% Range high 850.65 INR
vs 200-day avg 0% vs 50-day avg 0%

Illustrative technical + ownership context — a signal mix, not investment advice.

Performance

Raw-price comparisons begin at the captured split on Sep 13, 2024; windows that need an earlier baseline remain unavailable.

5D 20D 120D MTD YTD
XNSE:KIMS +0.9% +6.0% -4.5% +4.0% +19.9%

Exchange listing

Market
XNSE
Ticker
KIMS
ISIN
INE967H01025
Security
Ordinary share
Trading currency
INR

Company

Website
https://www.kimshospitals.com/
Investor relations
https://www.kimshospitals.com/Investors

Other listings of this company

Share classes and depositary receipts can have different prices and dividends.

Recent dividends

No verified dividend payments are available for this listing yet.

Upcoming investor events

No upcoming investor events are listed for this company yet.

Earnings calls

  • Earnings call · Q2 2027 2026-11-05 Audio Transcript
    Earnings Call
  • Earnings call · Q1 2027 2026-08-04 Audio Transcript
    Earnings Call
  • Earnings call · Q4 2026 2026-05-12
    Earnings Call